Gorzynski E A, Van Oss C J, Ambrus J L, Neter E
Infect Immun. 1972 Apr;5(4):625-6. doi: 10.1128/iai.5.4.625-626.1972.
Ten human volunteers were immunized intravenously with ethanol-soluble common enterobacterial antigen (CA) obtained from Escherichia coli O111. The immunogen contained 6 mg/ml, excluding salts. The antigen was given in amounts of 2 ml each in dilutions of 1:250 (48 mug) and 1:125 (96 mug), respectively, 1 week apart. Serum specimens were obtained prior to immunization and 1 week after the last injection. The CA hemagglutinins were titrated by means of the passive hemagglutination test, with CA from E. coli O14 as indicator antigen. The injections were well tolerated without side-effects by all subjects. A significant (> fourfold) increase in the titers of CA hemagglutinins was observed following immunization in 9 out of 10 volunteers. These results indicate the feasibility of immunization with CA of human subjects and suggest exploration of immunization against infection caused by Enterobacteriaceae producing this common enterobacterial antigen.
十名人类志愿者通过静脉注射从大肠杆菌O111中获得的乙醇可溶性常见肠道细菌抗原(CA)进行免疫。免疫原浓度为6毫克/毫升,不含盐。抗原分别以1:250(48微克)和1:125(96微克)的稀释度,每次注射2毫升,间隔1周给予。在免疫前和最后一次注射后1周采集血清样本。采用被动血凝试验,以大肠杆菌O14的CA作为指示抗原,对CA血凝素进行滴定。所有受试者对注射耐受性良好,无副作用。10名志愿者中有9名在免疫后观察到CA血凝素滴度显著(>四倍)升高。这些结果表明对人类受试者进行CA免疫的可行性,并建议探索针对产生这种常见肠道细菌抗原的肠杆菌科感染的免疫方法。